Days 67 Build Your Repeatable First-Week System By Days 6 and 7, your first week on GLP-1 may start to feel less mysterious
One exception to the injectable formulations is semaglutide (Rybelsus), which is available as an oral tablet
10 Recently, several clinical trials have shown the potential effects of these medications in not only in glycemic control but also in the improvement of cardiovascular outcomes, weight loss, osteoarthritis, 11 metabolic dysfunctionassociated steatohepatitis (MASH), 12 Parkinsons disease, 13 chronic kidney disease (CKD) 14 and obstructive sleep apnea
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, producing wide-ranging effects on appetite, digestion, and metabolism
doi: 10.2337/diabetes.52.1.102 125 FarillaLHuiHBertolottoCKangEBulottaADi MarioUet al
[1] [2] Long-term cardiovascular outcomes and the full safety profile of this mechanism in humans remain to be established in ongoing Phase 3 trials